|
Volumn 31, Issue 12, 2001, Pages 605-609
|
Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer
|
Author keywords
Chemotherapy; Cisplatin; Fluorouracil; Stomach neoplasms
|
Indexed keywords
ANTIEMETIC AGENT;
CISPLATIN;
FLUOROURACIL;
FOLINIC ACID;
SEROTONIN ANTAGONIST;
STEROID;
ADULT;
ADVANCED CANCER;
AGED;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLOOD TOXICITY;
BOLUS INJECTION;
CANCER GROWTH;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DISEASE SEVERITY;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG INFUSION;
DRUG MEGADOSE;
DRUG RESPONSE;
DUODENUM PERFORATION;
FATIGUE;
FEMALE;
HUMAN;
HYPERAMMONEMIA;
MALE;
MUCOSA INFLAMMATION;
NAUSEA AND VOMITING;
NEUROTOXICITY;
PHASE 2 CLINICAL TRIAL;
STOMACH CANCER;
|
EID: 0035707576
PISSN: 03682811
EISSN: None
Source Type: Journal
DOI: 10.1093/jjco/hye130 Document Type: Article |
Times cited : (20)
|
References (24)
|